Chandler Robinson insider trades

Open-market stock purchases and sales by Chandler Robinson, Chief Executive Officer at Monopar Therapeutics, from SEC Form 4 filings since Aug 9, 2018.

Recent trades

DateStockTradeValue
Mar 31, 2026MNPR Monopar TherapeuticsSold (not open market)$108K
Mar 31, 2026MNPR Monopar TherapeuticsBought (not open market)—
Dec 31, 2025MNPR Monopar TherapeuticsSold (not open market)$167K
Dec 31, 2025MNPR Monopar TherapeuticsBought (not open market)—
Dec 2, 2025MNPR Monopar TherapeuticsBought (not open market)—
Dec 2, 2025MNPR Monopar TherapeuticsBought (not open market)—

Companies traded

  • MNPR Monopar Therapeutics: 3 sales, last Mar 31, 2026
  • NONE Monopar Therapeutics: other filings, last Aug 9, 2018

Get free alerts when Chandler Robinson files a new trade →